Table 2.
Correlation of Pulmonary Artery Diameter With In-Hospital and 2-Month Continuous and Ordinal Outcomes
| Variable | Spearman rho | P value | N | 95% CI |
|---|---|---|---|---|
| NEWS2 score | 0.069 | .138 | 465 | −0.022 to 0.159 |
| Length of stay | 0.130 | .005 | 465 | 0.037 to 0.222 |
| PCFS @ discharge | 0.084 | .108 | 368a | −0.022 to 0.187 |
| PCFS @ 2-month | 0.121 | .021 | 365a | 0.016-0.221 |
| Discharge status | 0.117 | .023 | 375a | 0.018-0.212 |
| 2-month postdischarge status | 0.128 | .014 | 362a | 0.034-0.220 |
95% CIs for Spearman rho were built by bootstrapping based on 10,000 bootstrap samples. NEWS2, National Early Warning Score 2; PCFS, Post–COVID-19 Functional Status scale.
Valid sample size is slightly less than the number of survivors (n=379) because of missing data.